Abstract Library

#4510 Follow-up analysis of group nutritional education in patients with neuroendocrine neoplasms (GEDNEN Course): A novel approach with proven acceptability

Introduction: Structured group education demonstrates improved outcomes in peri-operative health optimisation and diabetes mellitus. We devised and delivered a novel in person nutrition/dietary education programme for patients with neuroendocrine neoplasms (NENs) at the Sheffield ENETS Centre of Excellence.

Conference:

Presenting Author: Munir A

Authors: Wen Loh E, Walsh E, Bisson H, Ahmed Z, Dancyger-Stevens L,

Keywords: Group Education, Nutrition, Neuroendocrine Neoplasm, Novel Tool,

#3990 Digestive neuroendocine tumors dignosis and therapeutic particularities: Experience of medical oncology center of Annaba, Algeria

Introduction: Digestive neuroendocrine tumors are a specific tumor entity because of its rarity they represent 1% of all digestive tumors and its heterogeneity both clinical and biological.

Conference:

Presenting Author: Bechairia W

Authors: Bechairia W,

Keywords: digestive neuroendocrine tumor, difficult diagnosis, medical treatment, benefit of multidisciplinary care,

#3834 The prognostic role of radiomics in gastroenteropancreatic neuroendocrine tumors

Introduction: Gastroenteropancreatic neuroendocrine neoplasia (GEP NENs) are rare and heterogenous diseases.

Conference:

Presenting Author:

Authors: Magi L, Polici M, Rinzivillo M, Caruso D, Zerunian M,

Keywords: radiomics, neuroendocrine tumor, prognosis, disease progression,

#3818 Somatostatin analogues or active surveillance in sporadic non-functioning pancreatic neuroendocrine tumors

Introduction: Non-functioning (NF), sporadic, G1-G2 pancreatic neuroendocrine tumors (PanNETs) usually display an indolent course. Surgery is the first-choice treatment for localized tumors >2 cm. Unresectable or metastatic PanNETs expressing somatostatin receptors (SSTRs) are treated with somatostatin analogues (SSAs). The PROMID and the CLARINET studies proved the SSA antiproliferative effect in advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The standard treatment for patients with PanNETs ≤2cm is active surveillance (AS). Yet no evidence of the value of SSA treatment exist in such patient population.

Conference:

Presenting Author: Maratta M

Authors: Maratta M, Chiloiro S, Raia S, Maiorano B, Rossi E,

Keywords: PanNET, somatostatin analogues, efficacy, surveillance, medical treatment,

#3809 Metastatic pattern and its prognostic value in well-differentiated neuroendocrine tumors

Introduction: The metastatic pattern of neuroendocrine tumors (NETs) and its potential prognostic value has not been well elucidated.

Conference:

Presenting Author:

Authors: Chen L, Yan X, Liu M, Lin Y, He Q,

Keywords: neuroendocrine tumor, metastasis, progression,